Praxis Precision Medicines, Inc.
Congress has disclosed 2 buys and 0 sells of PRAX (Praxis Precision Medicines, Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Round-trip watch Still on the books
Members who disclosed buying PRAX and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Gilbert Cisneros | 2026-09-29 | $281.00 | $286.26 | +1.9% | ↩ near entry |
Price as of 2026-11-02. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for —. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
2 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Gilbert Cisneros | House | BUY | Self · 150 Main Street Trust > Bank of America | 2026-09-29 | 10 days | -7.5% | $1K–$15K 0.1% of NW |
82.6 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider divergence | Self · 150 Main Street Trust > Bank of America | 2026-07-30 | 15 days | +19.2% | $1K–$15K 0.1% of NW |
84.6 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in PRAX — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in PRAX, 0 coincided with corporate insiders moving the same way within 60 days, and 1 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-06-24 | DeSimone Jill | Director | SELL 10b5-1 | $3K | ↗ EDGAR |
| 2026-06-24 | DeSimone Jill | Director | SELL 10b5-1 | $36K | ↗ EDGAR |
| 2026-06-24 | DeSimone Jill | Director | SELL 10b5-1 | $98K | ↗ EDGAR |
| 2026-06-24 | DeSimone Jill | Director | SELL 10b5-1 | $210K | ↗ EDGAR |
| 2026-06-24 | DeSimone Jill | Director | SELL 10b5-1 | $382K | ↗ EDGAR |
| 2026-06-24 | DeSimone Jill | Director | SELL 10b5-1 | $309K | ↗ EDGAR |
| 2026-06-24 | DeSimone Jill | Director | SELL 10b5-1 | $544K | ↗ EDGAR |
| 2026-06-24 | DeSimone Jill | Director | SELL 10b5-1 | $890K | ↗ EDGAR |
| 2026-06-24 | DeSimone Jill | Director | SELL 10b5-1 | $314K | ↗ EDGAR |
| 2026-06-24 | DeSimone Jill | Director | SELL 10b5-1 | $158K | ↗ EDGAR |
| 2026-06-24 | DeSimone Jill | Director | SELL 10b5-1 | $403K | ↗ EDGAR |
| 2026-06-24 | DeSimone Jill | Director | SELL 10b5-1 | $264K | ↗ EDGAR |
| 2025-11-20 | Mastrocola Lauren | Other | SELL | $2.2M | ↗ EDGAR |
| 2025-11-20 | Mastrocola Lauren | Other | SELL | $413K | ↗ EDGAR |
| 2025-11-20 | Nemiroff Alex | Other | SELL | $327K | ↗ EDGAR |
| 2025-11-20 | Nemiroff Alex | Other | SELL | $2.6M | ↗ EDGAR |
| 2025-11-20 | Nemiroff Alex | Other | SELL | $189K | ↗ EDGAR |
| 2025-11-20 | Nemiroff Alex | Other | SELL | $1.8M | ↗ EDGAR |
| 2025-10-16 | Adage Capital Management, L.P. | Other | SELL | $1.1M | ↗ EDGAR |
| 2025-10-16 | Adage Capital Management, L.P. | Other | SELL | $41K | ↗ EDGAR |
| 2025-10-16 | Adage Capital Management, L.P. | Other | SELL | $125K | ↗ EDGAR |
| 2025-10-16 | Adage Capital Management, L.P. | Other | SELL | $56K | ↗ EDGAR |
| 2025-10-16 | Adage Capital Management, L.P. | Other | SELL | $2.8M | ↗ EDGAR |
| 2025-10-16 | Adage Capital Management, L.P. | Other | SELL | $26.1M | ↗ EDGAR |
| 2025-10-16 | Adage Capital Management, L.P. | Other | SELL | $216K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| Congress | 2026-09-29 | Gilbert Cisneros | BUY | $1K–$15K |
| Congress | 2026-07-30 | Gilbert Cisneros | BUY | $1K–$15K |
| ◆ insider | 2026-06-24 | DeSimone Jill Director 10b5-1 | SELL | $3K |
| ◆ insider | 2026-06-24 | DeSimone Jill Director 10b5-1 | SELL | $36K |
| ◆ insider | 2026-06-24 | DeSimone Jill Director 10b5-1 | SELL | $98K |
| ◆ insider | 2026-06-24 | DeSimone Jill Director 10b5-1 | SELL | $210K |
| ◆ insider | 2026-06-24 | DeSimone Jill Director 10b5-1 | SELL | $382K |
| ◆ insider | 2026-06-24 | DeSimone Jill Director 10b5-1 | SELL | $309K |
| ◆ insider | 2026-06-24 | DeSimone Jill Director 10b5-1 | SELL | $544K |
| ◆ insider | 2026-06-24 | DeSimone Jill Director 10b5-1 | SELL | $890K |
| ◆ insider | 2026-06-24 | DeSimone Jill Director 10b5-1 | SELL | $314K |
| ◆ insider | 2026-06-24 | DeSimone Jill Director 10b5-1 | SELL | $158K |
| ◆ insider | 2026-06-24 | DeSimone Jill Director 10b5-1 | SELL | $403K |
| ◆ insider | 2026-06-24 | DeSimone Jill Director 10b5-1 | SELL | $264K |
| ◆ insider | 2025-11-20 | Mastrocola Lauren Other | SELL | $2.2M |
| ◆ insider | 2025-11-20 | Mastrocola Lauren Other | SELL | $413K |
| ◆ insider | 2025-11-20 | Nemiroff Alex Other | SELL | $327K |
| ◆ insider | 2025-11-20 | Nemiroff Alex Other | SELL | $2.6M |
| ◆ insider | 2025-11-20 | Nemiroff Alex Other | SELL | $189K |
| ◆ insider | 2025-11-20 | Nemiroff Alex Other | SELL | $1.8M |
| ◆ insider | 2025-10-16 | Adage Capital Management, L.P. Other | SELL | $1.1M |
| ◆ insider | 2025-10-16 | Adage Capital Management, L.P. Other | SELL | $41K |
| ◆ insider | 2025-10-16 | Adage Capital Management, L.P. Other | SELL | $125K |
| ◆ insider | 2025-10-16 | Adage Capital Management, L.P. Other | SELL | $56K |
FAQ Common questions
How much has Congress traded PRAX?
2 disclosed buys and 0 sells of PRAX (Praxis Precision Medicines, Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade PRAX?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.